We’ve recently updated our valuation analysis.

Crown Holdings Valuation

Is CCK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CCK?

Other financial metrics that can be useful for relative valuation.

CCK key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.4x
Enterprise Value/EBITDA58.4x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CCK's PS Ratio compare to its peers?

The above table shows the PS ratio for CCK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average1.2x
ATR AptarGroup
2.2x5.3%US$7.4b
BERY Berry Global Group
0.5x0.9%US$7.3b
BALL Ball
1.2x4.2%US$18.1b
SLGN Silgan Holdings
0.9x2.2%US$5.8b
CCK Crown Holdings
0.8x2.9%US$10.5b

Price-To-Sales vs Peers: CCK is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (1.2x).


Price to Earnings Ratio vs Industry

How does CCK's PE Ratio compare vs other companies in the US Packaging Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a6.0%
n/an/an/a

Price-To-Sales vs Industry: CCK is expensive based on its Price-To-Sales Ratio (0.8x) compared to the US Packaging industry average (0.8x)


Price to Sales Ratio vs Fair Ratio

What is CCK's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CCK PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.8x
Fair PS Ratio0.9x

Price-To-Sales vs Fair Ratio: CCK is good value based on its Price-To-Sales Ratio (0.8x) compared to the estimated Fair Price-To-Sales Ratio (0.9x).


Share Price vs Fair Value

What is the Fair Price of CCK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CCK ($88.45) is trading below our estimate of fair value ($165.1)

Significantly Below Fair Value: CCK is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CCK forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$88.45
US$94.81
+7.2%
11.0%US$106.00US$71.00n/a16
Jan ’24US$82.21
US$93.06
+13.2%
12.0%US$110.00US$71.00n/a17
Dec ’23US$82.73
US$92.35
+11.6%
12.3%US$110.00US$71.00n/a17
Nov ’23US$68.96
US$92.35
+33.9%
12.3%US$110.00US$71.00n/a17
Oct ’23US$81.03
US$122.06
+50.6%
10.8%US$151.00US$100.00n/a17
Sep ’23US$91.02
US$123.25
+35.4%
10.1%US$151.00US$103.00n/a16
Aug ’23US$100.67
US$123.88
+23.1%
10.0%US$151.00US$103.00n/a16
Jul ’23US$93.00
US$136.75
+47.0%
10.6%US$165.00US$110.00n/a16
Jun ’23US$104.34
US$139.25
+33.5%
9.3%US$165.00US$118.00n/a16
May ’23US$110.04
US$141.75
+28.8%
8.1%US$165.00US$123.00n/a16
Apr ’23US$125.76
US$141.19
+12.3%
7.4%US$165.00US$128.00n/a16
Mar ’23US$119.02
US$140.56
+18.1%
7.6%US$165.00US$128.00n/a16
Feb ’23US$116.03
US$133.47
+15.0%
8.5%US$165.00US$110.00n/a17
Jan ’23US$110.62
US$132.65
+19.9%
8.4%US$165.00US$110.00US$82.2117
Dec ’22US$105.50
US$132.65
+25.7%
8.4%US$165.00US$110.00US$82.7317
Nov ’22US$104.31
US$132.65
+27.2%
8.4%US$165.00US$110.00US$68.9617
Oct ’22US$100.08
US$129.93
+29.8%
6.1%US$140.00US$110.00US$81.0315
Sep ’22US$109.86
US$130.64
+18.9%
8.0%US$158.00US$110.00US$91.0214
Aug ’22US$99.76
US$130.64
+31.0%
8.0%US$158.00US$110.00US$100.6714
Jul ’22US$103.49
US$128.93
+24.6%
9.0%US$152.00US$110.00US$93.0014
Jun ’22US$103.17
US$128.93
+25.0%
9.0%US$152.00US$110.00US$104.3414
May ’22US$109.80
US$127.15
+15.8%
5.7%US$140.00US$115.00US$110.0413
Apr ’22US$100.38
US$117.86
+17.4%
12.7%US$135.00US$68.00US$125.7614
Mar ’22US$98.37
US$117.86
+19.8%
12.7%US$135.00US$68.00US$119.0214
Feb ’22US$91.82
US$110.57
+20.4%
12.1%US$125.00US$67.00US$116.0314
Jan ’22US$100.20
US$104.21
+4.0%
11.3%US$119.00US$67.00US$110.6214

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies